Literature DB >> 11571656

WNK kinases, a novel protein kinase subfamily in multi-cellular organisms.

F Veríssimo1, P Jordan.   

Abstract

We have cloned and characterized a novel human serine/threonine protein kinase gene from chromosome 12p13.3 encoding 2382 amino acids. Remarkably, the catalytic domain sequence contains a cysteine in place of a lysine residue conserved in subdomain II of most kinases. The same amino acid alteration was recently described for rat WNK1 (with no K=lysine) in which another nearby lysine residue was shown to confer kinase activity to the protein. Rat WNK1 is 85% identical to a splice variant lacking exons 11 and 12 of the described human kinase which we have called human WNK1. The WNK1 catalytic domain has closest homology with human PAK2, MEKK3, and Raf-1. Three additional, partial human protein kinase sequences, WNK2, WNK3 and WNK4, are also reported here with catalytic domains that are 95% homologous to WNK1. These genes differ both in chromosomal location and tissue-specific expression. Moreover, we have identified in the database a total of 18 WNK-related genes, all exclusively from multi-cellular organisms, which share a WNK kinase sequence signature within subdomains I and II of the catalytic domain. We suggest that they constitute a novel subfamily of protein kinases that evolved together with cell adhesion and tissue-formation.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11571656     DOI: 10.1038/sj.onc.1204726

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  109 in total

1.  Multiple promoters in the WNK1 gene: one controls expression of a kidney-specific kinase-defective isoform.

Authors:  Celine Delaloy; Jingyu Lu; Anne-Marie Houot; Sandra Disse-Nicodeme; Jean-Marie Gasc; Pierre Corvol; Xavier Jeunemaitre
Journal:  Mol Cell Biol       Date:  2003-12       Impact factor: 4.272

2.  WNK1, a kinase mutated in inherited hypertension with hyperkalemia, localizes to diverse Cl- -transporting epithelia.

Authors:  Keith A Choate; Kristopher T Kahle; Frederick H Wilson; Carol Nelson-Williams; Richard P Lifton
Journal:  Proc Natl Acad Sci U S A       Date:  2003-01-08       Impact factor: 11.205

3.  Genome-wide detection of tissue-specific alternative splicing in the human transcriptome.

Authors:  Qiang Xu; Barmak Modrek; Christopher Lee
Journal:  Nucleic Acids Res       Date:  2002-09-01       Impact factor: 16.971

Review 4.  Molecular diversity and regulation of renal potassium channels.

Authors:  Steven C Hebert; Gary Desir; Gerhard Giebisch; Wenhui Wang
Journal:  Physiol Rev       Date:  2005-01       Impact factor: 37.312

5.  WNK3 modulates transport of Cl- in and out of cells: implications for control of cell volume and neuronal excitability.

Authors:  Kristopher T Kahle; Jesse Rinehart; Paola de Los Heros; Angeliki Louvi; Patricia Meade; Norma Vazquez; Steven C Hebert; Gerardo Gamba; Ignacio Gimenez; Richard P Lifton
Journal:  Proc Natl Acad Sci U S A       Date:  2005-11-07       Impact factor: 11.205

6.  WNK1 protein kinase regulates embryonic cardiovascular development through the OSR1 signaling cascade.

Authors:  Jian Xie; Joonho Yoon; Sung-Sen Yang; Shih-Hua Lin; Chou-Long Huang
Journal:  J Biol Chem       Date:  2013-02-05       Impact factor: 5.157

7.  Overexpression of WNK1 in POMC-expressing neurons reduces weigh gain via WNK4-mediated degradation of Kir6.2.

Authors:  Woo Young Chung; Jung Woo Han; Woon Heo; Min Goo Lee; Joo Young Kim
Journal:  Mol Cell Biochem       Date:  2018-02-01       Impact factor: 3.396

Review 8.  The WNK signaling pathway and salt-sensitive hypertension.

Authors:  Taisuke Furusho; Shinichi Uchida; Eisei Sohara
Journal:  Hypertens Res       Date:  2020-04-14       Impact factor: 3.872

9.  Epigenome scans and cancer genome sequencing converge on WNK2, a kinase-independent suppressor of cell growth.

Authors:  Chibo Hong; K Scott Moorefield; Peter Jun; Kenneth D Aldape; Samir Kharbanda; Heidi S Phillips; Joseph F Costello
Journal:  Proc Natl Acad Sci U S A       Date:  2007-06-19       Impact factor: 11.205

Review 10.  Emerging Targets of Diuretic Therapy.

Authors:  C-J Cheng; A R Rodan; C-L Huang
Journal:  Clin Pharmacol Ther       Date:  2017-07-10       Impact factor: 6.875

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.